
Patients Email CEOs to Overturn Insurance Denials
Two patients secured coverage for critical treatments by directly contacting insurance company CEOs after traditional appeals failed.
Research areas on Bench to Bed: Oncology, Cardiovascular, Neurology and dementia, diabetes, obesity and GLP-1s.

Two patients secured coverage for critical treatments by directly contacting insurance company CEOs after traditional appeals failed.

Surgeons at a Missouri children's hospital successfully separated infant twin sisters born conjoined at the head earlier this year.

Kura Oncology has spun out a new biotech startup, Caspian Therapeutics, to develop menin inhibitor drugs for diabetes and cardiometabolic diseases.

Kura Oncology has created spinout Caspian Therapeutics, backed by $50 million from investors including Eli Lilly, to advance menin inhibitor KO-7246.

Novartis's pelacarsen, an antisense drug developed with Ionis to lower lipoprotein(a), did not reduce major cardiovascular events in high-risk patients.

A new Lancet Series argues that cardiovascular care in pregnancy must shift from reacting to crises to anticipating and managing long-term risk.

Verily Health, with NVIDIA and the NIH All of Us program, developed a foundation model combining EHR and genomic data. The model's performance for identifying high-risk Type 2 diabetes cases improved significantly, achieving a threefold pre-training efficiency gain.

A Lancet comment published August 21, 2026, discusses rezpegaldesleukin, a novel therapy designed to expand regulatory T cells.

A critical shortage of physicians with advanced Spanish skills is compromising care for millions of U.S. patients with limited English proficiency, a gap exacerbated by immigrants' fears of deportation. Research shows patients receiving direct Spanish-language care report better outcomes and greater trust than those relying on interpreters.

The SINGLE-AF trial found direct oral anticoagulants reduced cardiovascular events in atrial fibrillation patients with a single stroke risk factor.

The FDA has authorized the Aletta, a robotic blood draw device, for use in outpatient settings.

Health systems are increasingly using AI-powered chatbots to search and summarize patient records, helping clinicians uncover critical information buried in extensive medical histories. These tools, like ChatEHR, are proving valuable in diagnosing complex cases and improving efficiency in electronic health records.